PMA device
CAP24 Paddle Lead
Saluda Medical Pty, Ltd. · Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW, Class III) · First FDA decision Jun 29, 2026, newest Jun 29, 2026Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "CAP24 Paddle"
MAUDE reports
0
Brand "CAP24 Paddle", since 2015
PubMed studies
0
Mentioning "CAP24 Paddle"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing CAP24 Paddle Lead
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- CAP24 Paddle Lead, Passing Elevator, Evoke CLS (REF 3042), Clarity Programming Application (CPA), and RECAP ViewerPMA supplement
P190002-S039 · Decided Jun 29, 2026 · 454 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "CAP24 Paddle", any status and sponsor, newest update first.
No registered device study names "CAP24 Paddle".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CAP24 Paddle", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LGW
301,867 reports: 79,174 malfunction, 220,939 injury, 1,642 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "CAP24 Paddle"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LGW.
- Precision Spinal Cord Stimulator (SCS) SystemsBoston Scientific Corp · PMA 2026
- Senza Spinal Cord Stimulation (SCS) SystemNevro Corporation · PMA 2025
- Saluda Medical Evoke SCS SystemSaluda Medical Pty, Ltd. · PMA 2026
- Master RestoreMedtronic Neuromodulation · PMA 2026
- RestoreMedtronic Neuromodulation · PMA 2025
- Genesis and Eon Family Neurostimulation (Ipg) SystemsAbbott Medical · PMA 2016
- Genesis Neurostimulation SystemAbbott Medical · PMA 2024
- Precision Spectra Spinal Cord Stimulator (SCS) SystemBoston Scientific Corp · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.